What conditions have the most trials recruiting in Taegu, South Korea?

In Taegu, South Korea, the conditions with the most recruiting trials are Asthma (1), Breast Neoplasms (1), Breast cancer (1).

Clinical trials recruiting in Taegu, South Korea

Recruiting trials

Conditions

Phase 3 1Not applicable 2

Condition	Trials
Asthma	1
Breast Neoplasms	1
Breast cancer	1
HR Low-Positive/HER2-Negative Breast Neoplasms	1
High cholesterol	1
Primary Hypercholesterolemia or Mixed Dyslipidemia	1
Triple Negative Breast Neoplasms	1

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
NCT05217810 · Phase: Not specified · Ages: 12 Years to 100 Years · Sex: All (male and female)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
NCT06770543 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)

3 recruiting trials have at least one study site in Taegu, South Korea.

No. For the full record, search ClinicalTrials.gov.